Table 3.
Treatment | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | |
---|---|---|---|---|---|---|---|---|---|---|---|
(A) DISTANCE MATRIX ADULT SAMPLES | |||||||||||
(1) | CAT | . | 1 | 2 | 2 | 1 | 1 | 2 | 3 | 2 | 1 |
(2) | CBT | 1 | . | 1 | 3 | 2 | 2 | 1 | 2 | 1 | 2 |
(3) | CBT&X | 2 | 1 | . | 4 | 3 | 3 | 2 | 3 | 2 | 3 |
(4) | CBTE | 2 | 3 | 4 | . | 1 | 2 | 4 | 5 | 4 | 1 |
(5) | FPT | 1 | 2 | 3 | 1 | . | 1 | 3 | 4 | 3 | 1 |
(6) | FT_AN | 1 | 2 | 3 | 2 | 1 | . | 3 | 4 | 3 | 1 |
(7) | IPT | 2 | 1 | 2 | 4 | 3 | 3 | . | 2 | 1 | 3 |
(8) | MANTRA | 3 | 2 | 3 | 5 | 4 | 4 | 2 | . | 1 | 4 |
(9) | SSCM | 2 | 1 | 2 | 4 | 3 | 3 | 1 | 1 | . | 3 |
(10) | TAU | 1 | 2 | 3 | 1 | 1 | 1 | 3 | 4 | 3 | . |
(B) DISTANCE MATRIX ADOLESCENT SAMPLES. | |||||||||||
(1) | Complex-dh | . | 1 | 2 | 2 | 4 | 3 | 2 | 4 | 4 | 4 |
(2) | Complex-ip | 1 | . | 1 | 1 | 3 | 2 | 1 | 3 | 3 | 3 |
(3) | Complex-ipS | 2 | 1 | . | 2 | 4 | 3 | 2 | 4 | 4 | 4 |
(4) | Complex-op | 2 | 1 | 2 | . | 3 | 2 | 1 | 3 | 3 | 3 |
(5) | FST | 4 | 3 | 4 | 3 | . | 1 | 2 | 2 | 2 | 2 |
(6) | FT_AN | 3 | 2 | 3 | 2 | 1 | . | 1 | 1 | 1 | 1 |
(7) | FT_AN&X | 2 | 1 | 2 | 1 | 2 | 1 | . | 2 | 2 | 2 |
(8) | FT_ANsep | 4 | 3 | 4 | 3 | 2 | 1 | 2 | . | 2 | 2 |
(9) | MFT | 4 | 3 | 4 | 3 | 2 | 1 | 2 | 2 | . | 2 |
(10) | PD&X | 4 | 3 | 4 | 3 | 2 | 1 | 2 | 2 | 2 | . |
(A) k = 8 studies; n = 10 treatments; m = 17 pairwise comparisons; d = 7 designs; I2 = 0.8%; tau2 = 0.241, and Q = 13.9, df = 3, p = 0.0031. (B) k = 10 studies; n = 10 treatments; m = 12 pairwise comparisons; d = 8 designs; I2 = 0.8%; tau2 = 0.278, and Q = 8.12, df = 2, p = 0.0017.